Skip to main content
Top
Published in: Rheumatology International 12/2007

01-10-2007 | Original Article

Antiovarian antibodies in primary Sjogren’s syndrome

Authors: Kyriaki Euthymiopoulou, Alexios J. Aletras, Panagiota Ravazoula, Anna Niarakis, Dimitris Daoussis, Ioannis Antonopoulos, Stamatis-Nick Liossis, Andrew P. Andonopoulos

Published in: Rheumatology International | Issue 12/2007

Login to get access

Abstract

Our study aimed at screening patients with primary Sjogren’s syndrome (pSs) for the presence of antiovarian antibodies (AOAs). Detection of AOAs in patients’ sera was achieved by ELISA, using bovine ovarian extract for coating. Western blot analysis and immunohistochemistry were used to characterize the antibody targets in the extract and to determine their locus on the bovine ovary, respectively. Specific AOAs were detected in 27% of 37 patients (two with premature menopause) and in none of the controls. Immunoreactivity mainly resided in five proteins of the extract with molecular masses 42, 49, 55, 64 and 72 kDa, and it might be attributed to their carbohydrate components. The antibody targets were mainly located in the granulosa and theca interna cells of the follicle, and in the endothelial cells and fibroblasts of corpus luteum. The detection, for the first time, of AOAs in a significant percentage of patients with pSs may suggest autoimmune oophoritis, clinical or subclinical.
Literature
1.
go back to reference Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM (1980) Thyroid disease in Sjogren’s syndrome. Arthritis Rheum 23:1326–1329PubMedCrossRef Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM (1980) Thyroid disease in Sjogren’s syndrome. Arthritis Rheum 23:1326–1329PubMedCrossRef
2.
go back to reference Coulam CB, Adamson SC, Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604–606PubMed Coulam CB, Adamson SC, Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604–606PubMed
3.
go back to reference Moraes-Ruehsen M, Jones GS (1967) Premature ovarian failure. Fertil Steril 18:440–461PubMed Moraes-Ruehsen M, Jones GS (1967) Premature ovarian failure. Fertil Steril 18:440–461PubMed
5.
go back to reference Kalantaridou SN, Davis SR, Nelson LM (1998) Premature ovarian failure. Endocrin Metab Clin 27:989–1006CrossRef Kalantaridou SN, Davis SR, Nelson LM (1998) Premature ovarian failure. Endocrin Metab Clin 27:989–1006CrossRef
6.
go back to reference Board JA, Redwine FO, Moncure CW, Frable WJ, Taylor JR (1979) Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 134:936–944PubMed Board JA, Redwine FO, Moncure CW, Frable WJ, Taylor JR (1979) Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 134:936–944PubMed
7.
go back to reference Coulam CB, Kempers RD, Randall RV (1981) Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 36:238–240PubMed Coulam CB, Kempers RD, Randall RV (1981) Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 36:238–240PubMed
8.
go back to reference Coulam CB (1983) The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 4:63–66PubMed Coulam CB (1983) The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 4:63–66PubMed
9.
go back to reference Coulam CB, Ryan RJ (1985) Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 9:23–24PubMed Coulam CB, Ryan RJ (1985) Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 9:23–24PubMed
10.
go back to reference LaBarbera AR, Miller MM, Ober C, Rebar RW (1988) Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 16:115–122PubMed LaBarbera AR, Miller MM, Ober C, Rebar RW (1988) Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 16:115–122PubMed
11.
go back to reference Hoek A, Schoemaker J, Drexhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18:107–134PubMedCrossRef Hoek A, Schoemaker J, Drexhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18:107–134PubMedCrossRef
12.
go back to reference Forges T, Monnier-Barbarino P, Faure GC, Bene MC (2004) Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 10:163–175PubMedCrossRef Forges T, Monnier-Barbarino P, Faure GC, Bene MC (2004) Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 10:163–175PubMedCrossRef
13.
go back to reference Kamp P, Platz P, Nerup J (1974) ‘Steroid-cell’ antibody in endocrine diseases. Acta Endocrinol (Copenh) 76:729–740 Kamp P, Platz P, Nerup J (1974) ‘Steroid-cell’ antibody in endocrine diseases. Acta Endocrinol (Copenh) 76:729–740
14.
go back to reference Coulam CB, Ryan RJ (1979) Premature menopause. I. Etiology. Am J Obstet Gynecol 133:639–643PubMed Coulam CB, Ryan RJ (1979) Premature menopause. I. Etiology. Am J Obstet Gynecol 133:639–643PubMed
15.
go back to reference Elder M, Maclaren N, Riley W (1981) Gonadal autoantibodies in patients with hypogonadism and/or Addison’s disease. J Clin Endocr Metab 52:1137–1142PubMed Elder M, Maclaren N, Riley W (1981) Gonadal autoantibodies in patients with hypogonadism and/or Addison’s disease. J Clin Endocr Metab 52:1137–1142PubMed
17.
go back to reference Damewood MD, Zacur HA, Hoffman GJ, Rock JA (1986) Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 68:850–854PubMed Damewood MD, Zacur HA, Hoffman GJ, Rock JA (1986) Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 68:850–854PubMed
18.
go back to reference Sotsiou F, Bottazzo GF, Doniach D (1980) Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 39:97–111PubMed Sotsiou F, Bottazzo GF, Doniach D (1980) Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 39:97–111PubMed
19.
go back to reference Drury MI, Keelan DM, Timoney FJ, Irvine WJ (1970) Juvenile familial endocrinopathy. Clin Exp Immunol 7:125–132PubMed Drury MI, Keelan DM, Timoney FJ, Irvine WJ (1970) Juvenile familial endocrinopathy. Clin Exp Immunol 7:125–132PubMed
20.
go back to reference McNatty KP, Short RV, Barnes EW, Irvine WJ (1975) The cytotoxic effect of serum from patients with Addison’s disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol 22:378–384PubMed McNatty KP, Short RV, Barnes EW, Irvine WJ (1975) The cytotoxic effect of serum from patients with Addison’s disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol 22:378–384PubMed
21.
go back to reference Williamson HO, Phansey SA, Mathur S, Mathur RS, Baker ER, Fudenberg HH (1980) Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am J Obstet Gynecol 137:893–901PubMed Williamson HO, Phansey SA, Mathur S, Mathur RS, Baker ER, Fudenberg HH (1980) Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am J Obstet Gynecol 137:893–901PubMed
22.
go back to reference Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M, Aono T, Mori T (1992) Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 28:104–109PubMed Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M, Aono T, Mori T (1992) Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 28:104–109PubMed
23.
go back to reference Fenichel P, Sosset C, Barbarino-Monnier P, Gobert B, Hieronimus S, Bene MC, Harter M (1997) Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 12:2623–2628PubMedCrossRef Fenichel P, Sosset C, Barbarino-Monnier P, Gobert B, Hieronimus S, Bene MC, Harter M (1997) Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 12:2623–2628PubMedCrossRef
24.
go back to reference Aiman J, Smentek C (1985) Premature ovarian failure. Obstet Gynecol 66:9–14PubMed Aiman J, Smentek C (1985) Premature ovarian failure. Obstet Gynecol 66:9–14PubMed
25.
go back to reference Alper MM, Garner P (1985) Premature ovarian failure: Its relation to autoimmune disease. Obstet Gynecol 66:27–30PubMed Alper MM, Garner P (1985) Premature ovarian failure: Its relation to autoimmune disease. Obstet Gynecol 66:27–30PubMed
26.
go back to reference Pekonen F, Siegberg R, Makinen T, Miettinen A, Yli-Korkale O (1986) Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol 25:1–10 Pekonen F, Siegberg R, Makinen T, Miettinen A, Yli-Korkale O (1986) Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol 25:1–10
27.
go back to reference Mignot MH, Schoemaker J, Kleingeld M, Ramaneth R, Drexhape HA (1983) Premature ovarian failure: The association with autoimmunity. Eur J Obstet Gyn R B 30:59–66CrossRef Mignot MH, Schoemaker J, Kleingeld M, Ramaneth R, Drexhape HA (1983) Premature ovarian failure: The association with autoimmunity. Eur J Obstet Gyn R B 30:59–66CrossRef
28.
go back to reference Case records of the Massachusetts General Hospital (1986) Weekly clinicopathological exercises; Case 46-1986. N Engl J Med 315:1336–1343 Case records of the Massachusetts General Hospital (1986) Weekly clinicopathological exercises; Case 46-1986. N Engl J Med 315:1336–1343
29.
go back to reference Tang VW, Faiman C (1983) Premature ovarian failure: A search for circulating factors against gonadotropin receptors. Am J Obstet Gynecol 146:816–821PubMed Tang VW, Faiman C (1983) Premature ovarian failure: A search for circulating factors against gonadotropin receptors. Am J Obstet Gynecol 146:816–821PubMed
30.
go back to reference Collen RJ, Lippe BM, Kaplan SA (1979) Primary ovarian failure, juvenile rheumatoid arthritis and vitiligo. Am J Dis Child 133:598–600PubMed Collen RJ, Lippe BM, Kaplan SA (1979) Primary ovarian failure, juvenile rheumatoid arthritis and vitiligo. Am J Dis Child 133:598–600PubMed
31.
go back to reference Ayala A, Canales ES, Karchmer S, Alarcon D, Zarate A (1979) Premature ovarian failure and hypothyroidism associated with sicca syndrome. Obstet Gynecol 53:98S-101SPubMed Ayala A, Canales ES, Karchmer S, Alarcon D, Zarate A (1979) Premature ovarian failure and hypothyroidism associated with sicca syndrome. Obstet Gynecol 53:98S-101SPubMed
32.
go back to reference Vitali C, Bombardieri S, Moutsopoulos HM, Belestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S et al (1993) Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340–347PubMedCrossRef Vitali C, Bombardieri S, Moutsopoulos HM, Belestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S et al (1993) Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340–347PubMedCrossRef
33.
go back to reference Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRef Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRef
34.
go back to reference Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E, Aletras AJ (2001) Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28:1319–1329PubMed Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E, Aletras AJ (2001) Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28:1319–1329PubMed
35.
go back to reference Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMed Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMed
36.
go back to reference Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef
37.
go back to reference Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 26:1087–1093PubMed Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 26:1087–1093PubMed
38.
go back to reference Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C (1989) Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 84:1857–1865PubMedCrossRef Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C (1989) Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 84:1857–1865PubMedCrossRef
39.
go back to reference Cabral de Sousa D, das Chagas Medeiros MM, Trindale Viana VS, Salani Mota RM (2005) Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto’s thyroiditis. Lupus 14:618–624CrossRef Cabral de Sousa D, das Chagas Medeiros MM, Trindale Viana VS, Salani Mota RM (2005) Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto’s thyroiditis. Lupus 14:618–624CrossRef
40.
go back to reference Sunblad V, Bussmann L, Chiauzzi VA, Pancholi V, Charreau EH (2006) α-enolase: a novel autoantigen in patients with premature ovarian failure. Clin Endocrinol 65:745–751CrossRef Sunblad V, Bussmann L, Chiauzzi VA, Pancholi V, Charreau EH (2006) α-enolase: a novel autoantigen in patients with premature ovarian failure. Clin Endocrinol 65:745–751CrossRef
41.
go back to reference Moncayo-Naveda H, Moncayo R, Benz R, Wolf A, Lauritzen C (1989) Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol 160:1227–1229PubMed Moncayo-Naveda H, Moncayo R, Benz R, Wolf A, Lauritzen C (1989) Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol 160:1227–1229PubMed
42.
go back to reference Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ, Rust PF, Fudenberg HH (1982) Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 50:259–266PubMed Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ, Rust PF, Fudenberg HH (1982) Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 50:259–266PubMed
43.
go back to reference Lucky AW, Rebar RW, Blizzard RM, Coren EM (1977) Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies. J Clin Endocr Metab 45:673–678PubMedCrossRef Lucky AW, Rebar RW, Blizzard RM, Coren EM (1977) Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies. J Clin Endocr Metab 45:673–678PubMedCrossRef
44.
go back to reference Forges T, Monnier-Barbarino P, Guillet-May F, Faure GC, Béné MC (2006) Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study. Eur J Clin Pharmacol 62:699–705PubMedCrossRef Forges T, Monnier-Barbarino P, Guillet-May F, Faure GC, Béné MC (2006) Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study. Eur J Clin Pharmacol 62:699–705PubMedCrossRef
45.
go back to reference Bateman BG, Nunley WC, Kitchin JD 3rd (1983) Reversal of apparent premature ovarian failure in a patient with myasthenia gravis. Fertil Steril 39:108–110PubMed Bateman BG, Nunley WC, Kitchin JD 3rd (1983) Reversal of apparent premature ovarian failure in a patient with myasthenia gravis. Fertil Steril 39:108–110PubMed
46.
go back to reference Lundberg PO, Persson BH (1969) Disappearance of amenorrhea after thymectomy. A case report. Acta Soc Med Ups 74:206–208PubMed Lundberg PO, Persson BH (1969) Disappearance of amenorrhea after thymectomy. A case report. Acta Soc Med Ups 74:206–208PubMed
Metadata
Title
Antiovarian antibodies in primary Sjogren’s syndrome
Authors
Kyriaki Euthymiopoulou
Alexios J. Aletras
Panagiota Ravazoula
Anna Niarakis
Dimitris Daoussis
Ioannis Antonopoulos
Stamatis-Nick Liossis
Andrew P. Andonopoulos
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0364-z

Other articles of this Issue 12/2007

Rheumatology International 12/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.